News
Bristol-Myers Squibb managed to surpass revenue expectations by a comfortable 4.6%, yet suffered an inconvenient earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback